Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

survival

  • Open Access
    Cytoreductive Surgery and HIPEC for Malignant Peritoneal Mesothelioma: Outcomes and Survival From an Australian Centre
    RAPHAEL SHAMAVONIAN, ERNEST CHENG, JOSH B. KARPES, SHOMA BARAT, NIMA AHMADI and DAVID L. MORRIS
    Anticancer Research June 2022, 42 (6) 2939-2944; DOI: https://doi.org/10.21873/anticanres.15776
  • You have access
    Bevacizumab-based Salvage Chemotherapy Improves Survival Outcomes for Patients With Brain Metastasis from Ovarian Cancer
    SHINICHI TATE, KYOKO NISHIKIMI, AYUMU MATSUOKA, SATOYO OTSUKA and MAKIO SHOZU
    Anticancer Research May 2022, 42 (5) 2637-2644; DOI: https://doi.org/10.21873/anticanres.15741
  • You have access
    Prognostic Impact of Immune-related Adverse Events in Gastric Cancer Patients Treated With Nivolumab
    HIDEAKI SUEMATSU, KAZUKI KANO, TAKANOBU YAMADA, ITARU HASHIMOTO, HAYATO WATANABE, KOSUKE TAKAHASHI, MAMORU WATANABE, KEI HAYASHI, YOSHIHIRO KANETA, MITSUHIRO FURUTA, YASUHIRO INOKUCHI, NOZOMU MACHIDA, TORU AOYAMA, HIROSHI TAMAGAWA, NORIO YUKAWA, YASUSHI RINO, MUNETAKA MASUDA, TAKASHI OGATA and TAKASHI OSHIMA
    Anticancer Research March 2022, 42 (3) 1535-1540; DOI: https://doi.org/10.21873/anticanres.15626
  • You have access
    Death Receptor 6 as a Prognostic Marker in Low-grade Glioma
    SARAH K. STEGMANN, SASKIA KUHL, NAM GYU IM, DANG THUY DIEM-DINH, LUKAS GOERTZ, ROLAND GOLDBRUNNER and MARCO TIMMER
    Anticancer Research March 2022, 42 (3) 1237-1245; DOI: https://doi.org/10.21873/anticanres.15591
  • You have access
    Prognostic Significance of 3-Month Prostate-specific Antigen Level Following Androgen-deprivation Therapy in Metastatic Hormone-sensitive Prostate Cancer
    YUJIRO NAGATA, TAKUO MATSUKAWA, IKKO TOMISAKI and NAOHIRO FUJIMOTO
    Anticancer Research February 2022, 42 (2) 1107-1114; DOI: https://doi.org/10.21873/anticanres.15573
  • You have access
    Sacral Chordoma: A Population-based Analysis of Epidemiology and Survival Outcomes
    MATTEO SCAMPA, ENRICO TESSITORE, DENNIS E. DOMINGUEZ, DIDIER HANNOUCHE, NICOLAS C. BUCHS, DANIEL F. KALBERMATTEN and CARLO M. ORANGES
    Anticancer Research February 2022, 42 (2) 929-937; DOI: https://doi.org/10.21873/anticanres.15552
  • You have access
    Intensified Total Neoadjuvant Therapy Versus Intensified Concurrent Chemoradiotherapy in Locally Advanced Rectal Cancer: A Propensity Score Matching Analysis
    FRANCESCA DE FELICE, DANIELA MUSIO, FRANCO IAFRATE, SALVATORE CAPONNETTO, VINCENZO PICONE, GIANCARLO D’AMBROSIO, FABIO MASSIMO MAGLIOCCA, FRANCESCA TOZZI, GIORGIO DE TOMA, VINCENZO TOMBOLINI and ENRICO CORTESI
    Anticancer Research February 2022, 42 (2) 991-1000; DOI: https://doi.org/10.21873/anticanres.15559
  • You have access
    Survival After Minimally Invasive Surgery in Older Women With Endometrial Carcinoma
    JOEL CARDENAS-GOICOECHEA, YU WANG, JI-HYUN LEE, MASSOUD SHORAKA, SEMIRAMIS L. CARBAJAL-MAMANI, DAVID FISHMAN, ANDREA N. RINER and JOSE G. TREVINO
    Anticancer Research January 2022, 42 (1) 75-85; DOI: https://doi.org/10.21873/anticanres.15459
  • You have access
    The Benefit of Postoperative Radiotherapy and Extending Neck Dissection in pT1-2 Oral Squamous Cell Carcinoma With a Single Ipsilateral Cervical Lymph Node Metastasis (pN1)
    UBAI ALSHARIF, DANIEL STELLER, MOHAMED FALOUGY, LARS THARUN, DIRK RADES and SAMER G. HAKIM
    Anticancer Research January 2022, 42 (1) 97-104; DOI: https://doi.org/10.21873/anticanres.15462
  • You have access
    Lung Cancer in Non-smokers in Czech Republic: Data from LUCAS Lung Cancer Clinical Registry
    ONDREJ VENCLICEK, JANA SKRICKOVA, KRISTIAN BRAT, ONDREJ FISCHER, LIBOR HAVEL, MICHAL HRNCIARIK, MILOSLAV MAREL, PETR OPALKA, GABRIELA KRAKOROVA, DENISA ROZSIVALOVA, JURAJ KULTAN, ANDREA MULLEROVA, LYDIA ZARNAYOVA, PETRA SMICKOVA, MARTINA VASAKOVA, ZSUZSANNA GYORFY, MICHAL JIROUSEK, DANIEL KREJCI, JANA KREJCI, PETR ZUNA, MARTIN SVATON, KRISTYNA HRDA, JAROSLAV DUBA, JANA ALAHAKOON, MICHAL SVOBODA and JIRI SILAR
    Anticancer Research November 2021, 41 (11) 5549-5556; DOI: https://doi.org/10.21873/anticanres.15368

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 24
Anticancer Research

© 2022 Anticancer Research

Powered by HighWire